NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $269,000 | -80.6% | 1,930 | -83.4% | 0.01% | -78.6% |
| Q2 2020 | $1,387,000 | +102.2% | 11,607 | +69.1% | 0.04% | +121.1% |
| Q1 2020 | $686,000 | -11.6% | 6,865 | +4.0% | 0.02% | +35.7% |
| Q4 2019 | $776,000 | -7.0% | 6,599 | -31.4% | 0.01% | +16.7% |
| Q1 2018 | $834,000 | -10.4% | 9,622 | -3.2% | 0.01% | 0.0% |
| Q1 2017 | $931,000 | -7.0% | 9,939 | +3.7% | 0.01% | -7.7% |
| Q3 2016 | $1,001,000 | +13.8% | 9,589 | -19.6% | 0.01% | +18.2% |
| Q2 2016 | $880,000 | +137.2% | 11,924 | +54.0% | 0.01% | +266.7% |
| Q1 2015 | $371,000 | +58.5% | 7,742 | +27.8% | 0.00% | +50.0% |
| Q4 2014 | $234,000 | – | 6,058 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
| Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
| Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
| Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
| Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
| Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
| Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
| ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
| PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |